REFEREE REPORTS
Referee #1:
General comment The "CSS-motif" domain entry in the Pfam database has been created several years ago but until now the functions of this domain remained unknown. This protein domain is found in more than 5,000 proteins in UniProt, almost always in association with the c-di-GMP-specific phosphodiesterase (EAL) domain. Both E. coli and Salmonella Typhimurium genomes carry five such genes, which indicates that these proteins must perform some crucial cellular function. The reviewed manuscript finally sheds light on the functions of these proteins and their CSS domains. This is a well-written paper presenting a very impressive work which uncovers the mechanism that allows regulation of biofim formation by the redox status and proteolytic activity in the cell periplasm. That said, this manuscript could benefit from clarification of the following issues.
1. Although the transmembrane segment TM1 of PdeC does not look like a signal peptide, has it been shown experimentally, e.g. by N-terminal sequencing or mass-spectrometry, that it does not get cleaved? In other words, how do we know that the CSS domain is anchored in the membrane from both sides and not just by TM2? 2. The 33-kD proteolytic fragments on Fig. 2 and Fig. 3 form pretty tight bands, rather than smudges often produced by non-specific proteolysis. If, as these gels suggest, proteolysis occurs at a specific point of the PdeC sequence, it would be helpful to define this point (again by N-terminal sequencing or mass-spectrometry), rather than just put it somewhere around amino acid 215 (lines 215-216 of the text).
3. This work deals with the redox regulation of PdeC during the transition to the stationary phase in aerobic conditions. The most physiologically relevant for E.coli would be transition between aerobiosis and anaerobiosis (as in the human gut). It would be important to show that the transition from the oxidized form of PdeC to the reduced form, achieved by the DTT exposure in Fig. 2B , could also occur in vivo, during the switch from an aerobic to anaerobic environment. 4 . The data presented on Fig. 4 and S4 show that the TM2-EAL construct localizes to the membrane fraction and is enzymatically active. Clearly, this fragment adopts the correct orientation with respect to the membrane, which allows dimerization of the EAL domain. However, calling TM2 a dedicated dimerization domain is probably a stretch. Its sequence does not contain any residues that would make TM2 likely to form stable dimeric patches. Further, there could be any number of reasons why replacement of TM2 with TM2* did not work, including the possibility that TM2* simply did not properly insert into the membrane. It would be a good idea to soften the language on lines 241 and 658. 5. A very attractive feature of the presented model (Fig. 5) is the inherent temporary response of the CSS-EAL system, which is only active until either the CSS domain gets oxidized or the EAL domain gets proteolytically cleaved from the membrane. This might be worth a brief discussion. Minor comments. -Line 94. After "proteins", add "respectively". -Line 143. Change "replaced the functionally important EAL motif by AAL" to "replaced the active site glutamate of the EAL motif by alanine". -Line 150. Change "AAL mutation" to "EAL to AAL mutation" -Line 156. Replace "determining" by "monitoring two c-di-GMP-dependent functions:" -Line 161. Mentioning "the potential to form a DSB" looks a bit premature here, until the presentation of the DTT data. You might want to say that "presence of both Cys75 and Cys106 of the CSS domain results in a lower PDE activity of PdeC, whereas the replacement of one or both of them promotes PdeC activity. This suggested a possible link to the potential of these Cys residues to form a DSB". -Lines [189] [190] 202 , and elsewhere in the text. "cys75 and cys106" should be "Cys75 and Cys106" - Fig. S3 . The UniProt entry for PdeC http://www.uniprot.org/uniprot/P32701 lists slightly shorter transmembrane segments (14-34) and (242-262), which is consistent with the alignment on Fig. S1 . -Fig. 5 . The presented scheme looks very nice but the positions of the cysteines give the impression that the distance between them (which is 30 aa) is equal or greater than the distance from Cys105 to the TM2 (which is actually 120 aa).
Referee #2:
In bacteria, biofilm formation is promoted by the second messenger c-di-GMP. This molecule is synthesized by diguanylate cyclases and degraded by specific phosphodiesterases. The cellular levels of c-di-GMP depend on the balance between these two classes of enzymes. In this manuscript, Herbst et al investigate the physiological function of a group of five phosphodiesterases expressed by E. coli. These enzymes are characterized by the presence of a periplasmic domain in which two conserved cysteine residues are present. Focusing on one of the five phosphodiesterases, PdeC, the authors demonstrate that formation of a disulfide bond between these two cysteines reduces PdeC phosphodiesterase activity. By contrast, preventing disulfide bond formation by deleting DsbA or DsbD, or reducing the disulfide by adding DTT, activates the enzyme. The authors also show that reduction of the disulfide induces the enzymatic degradation of the periplasmic portion of PdeC by the proteases DegP and DegQ and that the second TM domain of PdeC acts as a dimerization domain promoting phosphiesterase activity. On the basis of these results, they propose an elegant mechanism in which the phosphodiesterase activity of PdeC is controlled through redox regulation and dimerization. Overall this paper is interesting and the data nicely support the proposed mechanism. The detailed mechanistic study is quite impressive and informative. The conservation of two cysteine residues that form a disulfide in a protein does not necessarily indicate that this protein is redox-regulated. This disulfide might only be required for structural stability. My major concern is that the authors fail to provide data supporting the physiological relevance of their findings. In the discussion, the authors suggest that decreased oxygen concentrations may favor reduction (absence of formation) of the PdeC disulfide and therefore activate the enzyme. Maybe. But, as the authors mention, the DsbA/DsbB system has been shown to function anaerobically, so this might not be the case. I think that some experimental evidence that oxygen limitation is the physiological signal activating PdeC activity is required for publication in a journal like EMBO. Minor comments: -E.coli has 4 additional enzymes like PdeC. In this study, they have only tested one. It would be interesting to test the importance of disulfide bond formation on the activity for at least one of the other enzymes (using the macrocolony morphology assay for example).
-The authors could comment more on the interest for E. coli to produce fragments by proteolysis if the full size protein is capable of PDE activity Herbst et al. present interesting set of observations suggesting involvement of the periplasmic CSS motif (protein domain) in regulating E. coli c-di-GMP phosphodiesterase (PDE), PdeC. Their study offers genetic evidence (using mutants in the periplasmic disulfide bond formation apparatus) that a disulfide bond is formed between two highly conserved Cys residues in the CSS motif. It further suggests that addition of a strong reducing agent results in the proteolysis of the CSS motif via the periplasmic proteases DegP and DegQ. Proteolysis also takes place when the Cys residues are mutated. Interestingly, a proteolytically processed (truncated) version that lacks the CSS motif but retains a single transmembrane motif (TM2), which is involved in protein dimerization, is catalytically active, and potentially more active than the native PdeC protein.
Overall, this is an interesting story that, however, has some large experimental gaps. Further, it presents a conclusion about the physiological significance of PdeC regulation that contradicts earlier literature reports. Filling the gaps is critical for this story to see the prime time, certainly for a highprofile journal.
MAJOR CONCERNS 1. One key problem with this study is that, while it presents some evidence that an intramolecular disulfide bond is formed within the CSS motif, the evidence is indirect. What is absent is a demonstration and quantification of the disulfide-versus non-disulfide CSS motifs under 'normal' and 'reducing' conditions. The reason why this is critical is because several alternative explanations exist, e.g. mixed disulfides with proteins that interact with the CSS motif in the periplasm.
2. Physiological assays suggest that the proteolytically processed (truncated) form of PdeC has higher PDE activity than the full-length form. However, this argument is not supported by protein quantification that needs to show that the full-length and truncated forms are present in the same concentrations in cells. What would make the authors' argument even more convincing is their comparing PDE activities of the full-length and truncated proteins in vitro.
3. Another major concern is that the study lacks convincing physiological role of PdeC. (i) All data related to physiology are based on protein overexpression. PdeC deletion makes very little effect.
(ii) Since reducing conditions are presented as the signal to activate PdeC, tests of the pdeC mutant need to be run in the presence and absence of reducing agents. What is troublesome is that the proposed model of increased PDE activity in E. coli under reducing conditions directly contradicts known physiological responses of this bacterium. . These heme-containing enzymes also respond to reducing conditions by increasing c-di-GMP levels and inducing biofilm components. It is possible that each system is unique to some specific media, temperature or other conditions. It is also possible that the authors' predictions here are wrong and that the target for PdeC is different than biofilms. (Perhaps motility?) The contradiction with known physiological responses of E. coli to reducing conditions requires an explanation or further investigation.
4. The last point of concern is a grossly inadequate referencing style of this manuscript.
-The authors neglect to reference in the main text highly relevant sets of papers highlighted in issue #3 that deal with the effects of reducing conditions on E. coli biofilms.
-Further, most references in Introduction are biased toward the senior author's group. There is nothing wrong with self-citations where appropriate, yet this manuscript clearly does so in an unjustifiable way. A reader unfamiliar with the field would be left with an impression that the senior author's laboratory has done all the discovery and mechanistic work on curli and cellulose components in E. coli, as well as their regulation. The toxicity of overexpression of the TM2-EAL construct in the BTH assay is highly problematic. If TM2-EAL protein is toxic, then it is possible that nonspecific toxicity, instead of higher PDE activity, is responsible for the observed phenotypes. Therefore, showing that TM2-EAL dimerize in the "wild-type" background is essential. The simplest solution is to change the multicopy BTH vector to a low-copy vector. 
Response to Reviewers
In response to the reviewers´ comments, we performed a substantial number of new experiments and the manuscript and supplementary information were extensively and thoroughly worked over. The new experiments led to three additional new figures and in short are the following:
• PdeC expressed at physiological levels (from its chromosomal gene, labeled with a C-terminal Flag tag) is now shown to show the same response to DTT, redox control by DsbA and proteolysis by DegP/DegQ (new Fig. 5A ).
• The same is now shown for a second CSS domain PDE (PdeB) and also for PdeB, the non-DSB variant PdeBASS is demonstrated to be more active than PdeBwt (new Fig. 5A and B).
• We purified detergent-solubilized PdeC and reconstituted it into nanodiscs (in the absence of reducing agent). Reconstituted PdeC not only showed PDE activity in vitro, but above all the addition of DTT stimulated PDE activity. Since PdeCwt also contains three cytoplasmic cysteine residues (in the EAL domain), which may possibly form illegitimate DSBs during preparation that are likely to interfere with PDE activity, we also generated a PdeC variant with these 3 cytoplasmic cysteines replaced by serines as well as a chimeric protein consisting of the TM1+CSS+TM2 region of PdeC fused to the naturally cysteinefree EAL domain of PdeN (which is one of the other four CSS domain PDEs). When purified and nanodisc-reconstituted, also these two constructs show higher PDE activity in the presence of DTT. All this (as well as in vivo activity in macrocolonies of these constructs) is now shown in the new Fig. 6 .
• Finally, we show a physiological activity of PdeC (chromosomally encoded; shown in comparison to mutants lacking PdeC or all five CSS domain PDEs) directly in situ in biofilms: PdeC and additional CSS domain PDEs are involved in controlling the production and supracellular architecture of the extracellular matrix specifically in the deeper layers of mature macrocolony biofilms (new Fig. 7 ). This finding and its relationship to the steep oxygen gradient found in this type of thick biofilm is now discussed in detail in a new section on the physiological function of PdeC and CSS domain PDEs in the Discussion.
Furthermore, we have dealt with all comments made by the referees -thank you for their constructive comments and the significant amount of work they have put into this!
Here are the responses to all comments in detail:
General comment
The A: The following evidence argues against cleavage of TM1:
• TM1 does not end with a signal peptidase cleavage site (A/GxA);
• PdeCΔperi (= TM1+TM2+EAL) is clearly of larger size than TM2+EAL; this construct actually contains the 9 amino acids just following TM1 (K34 to R43) as a small periplasmic loop that allows TM1 and TM2 to adopt their natural positions and functions; if there were a signal peptide cleavage site at the end of TM1, it would be intact;
• we now also show that PdeC does not accumulate as a larger precursor protein in a secA(ts) mutant at non-permissive temperature (see new Fig. S8 )
The 33-kD proteolytic fragments on Fig. 2 and Fig. 3 form pretty tight bands, rather than smudges often produced by non-specific proteolysis. If, as these gels suggest, proteolysis occurs at a specific point of the PdeC sequence, it would be helpful to define this point (again by N-terminal sequencing or mass-spectrometry), rather than just put it somewhere around amino acid 215 (lines 215-216 of the text).
A: DegP and DegQ are processive proteases, i.e. they recognize unfolded regions of substrate proteins and then processively degrade from this initial recognition site (Clausen et al, 2011). The point in the sequence of PdeC where they stop is determined by the fact that PdeC enters the membrane with TM2 and DegP/DegQ cannot 'pull' it out of the membrane (as periplasmic proteases, they do not have an ATPase function). That this stop is at a certain distance upstream from the beginning of TM2 reflects the geometry of DegP and DegQ, which have relatively large quaternary structures with the catalytic/proteolytic site inside the protease complexes. In other words, the position in PdeC where the two proteases stop to degrade is not a specific recognition/cleavage site but it is at a certain distance from the beginning of TM2. All this is discussed on p. 8, top paragraph. Fig. 2B , could also occur in vivo, during the switch from an aerobic to anaerobic environment.
This work deals with the redox regulation of PdeC during the transition to the stationary phase in aerobic conditions. The most physiologically relevant for E.coli would be transition between aerobiosis and anaerobiosis (as in the human gut). It would be important to show that the transition from the oxidized form of PdeC to the reduced form, achieved by the DTT exposure in
A: We now show that PdeC and additional CSS domain PDEs (expressed from their genes on the chromosome) are active in vivo in the deeper layers of mature macrocolony biofilms, where they contribute to determine production and supracellular architecture of the extracellular matrix (see new Fig. 7 ). Since these biofilms are characterized by steep oxygen gradients (Dietrich et al., 2013), this indeed suggests that the redox state and activity of PdeC and other CSS domain PDEs change when cells transit from aerobic to microaerobic/anaerobic conditions (for a more detailed discussion, see p. 17). Fig. 4 A: We agree that the finding that the presence of TM2 promotes dimerisation formally does not prove that it is a 'dimerisation domain' per se. Alternatively, it may affect the structure of the EAL domain in a manner that allows the EAL domain to dimerize. Membrane association alone does not seem to promote dimerisation, since the PdeCTM2* construct did properly localize to the membrane fraction. To reflect this, we rephrased from TM2 being 'a dimerisation domain' to 'promotes dimerisation of PdeC'. (Fig. 5) A: This is now discussed more clearly both in the first part (p. 14) as well as on p. 16 by pointing out that PdeC has several 'options': (i) being oxidized by DsbA/DsbB, (ii) staying reduced/more active and/or (iii) being processed by DegP/DegQ); the latter activates in a non-reversible manner, which therefore calls for further proteolysis as a terminal inactivation mechanism. Which of these options 'wins' or dominates, depends mainly on the activity of the DsbA/DsbB system, which in turn is affected by oxygen as a terminal electron acceptor. An interesting side observation of the new temperature shift experiment with wildtype and secA(ts) strains (Fig. S8 ) is that at non-permissive temperature (42oC) processing of PdeCwt is stimulated, which is likely to reflect increased levels of DegP (which is a heat shock protein) as well as increased activity of DegP as a protease (DegP acts both as a chaperone and as a protease, with the latter activity being stimulated at higher temperatures; see Krojer et al, 2002). Fig. 1 Fig. S1 . A: The algorithm used by UniProt seems very stringent. Amino acids 8-13 are QLLALP, which I think qualifies as hydrophobic. Amino acids 235-241 are LITHFYN, which is of intermediate hydrophobicity. For our TM2+EAL constructs we just decided to leave these amino acids in the construct in order to be on the safe side and not to cut away too much.
The data presented on

A very attractive feature of the presented model
The description of
- Fig. 5 .
The presented scheme looks very nice but the positions of the cysteines give the impression that the distance between them (which is 30 aa) is equal or greater than the distance from Cys105 to the TM2 (which is actually 120 aa).
A: This is not drawn to scale, but we agree and have changed it in the figure.
Referee #2:
In bacteria, biofilm formation is promoted by the second messenger c-di-GMP. This molecule is synthesized by diguanylate cyclases and degraded by specific phosphodiesterases. The cellular levels of c-di-GMP depend on the balance between these two classes of enzymes. In this manuscript, Herbst et al investigate the physiological function of a group of five phosphodiesterases expressed by E. coli. These enzymes are characterized by the presence of a periplasmic domain in which two conserved cysteine residues are present. Focusing on one of the five phosphodiesterases, PdeC, the authors demonstrate that formation of a disulfide bond between these two cysteines reduces PdeC phosphodiesterase activity. By contrast, preventing disulfide bond formation by deleting DsbA or DsbD, or reducing the disulfide by adding DTT, activates the enzyme. The authors also show that reduction of the disulfide induces the enzymatic degradation of the periplasmic portion of PdeC by the proteases DegP and DegQ and that the second TM domain of PdeC acts as a dimerization domain promoting phosphiesterase activity. On the basis of these results, they propose an elegant mechanism in which the phosphodiesterase activity of PdeC is controlled through redox regulation and dimerization. Overall this paper is interesting and the data nicely support the proposed mechanism. The detailed mechanistic study is quite impressive and informative. The conservation of two cysteine residues that form a disulfide in a protein does not necessarily indicate that this protein is redox-regulated. This disulfide might only be required for structural stability.
A: We agree that DSBs can have either a structural or a regulatory role (Wouters et al. 2010). The former is the case for many periplasmic proteins, for which DSB formation is required to fold into the native and active conformation. However, in the case of PdeC (and now also shown for PdeB), it is the reduced form that is more active, which already argues against a structural role of DSB formation. Fig. 5 ).
My major concern is that the authors fail
-The authors could comment more on the interest for E. coli to produce fragments by proteolysis if the full size protein is capable of PDE activity
A: Proteolysis by DegP/DegQ may be seen as a by-product of partial unfolding of the CSS domain that comes along with opening of the DSB; however, it is also a way of achieving slow turnover of PdeC and other CSS domain PDEs. Notably, 4 of the 5 CSS domain PDEs are under σS control, i.e. they are mainly expressed in slowly growing and/or stationary phase cells, in which proteins are no longer subject to divisionassociated dilution. Thus, in stationary phase the only way to eventually reduce or even get rid of a cellular protein is by proteolysis.
-line 174 : a a periplasmic DSB A: Done.
-line 235 : Fig 3B instead of 4B
A: Done.
-line 377 : limitation instead of limitaton
A: Done. (Fig. S5 ). This bands corresponds in size to a PdeC dimer and again completely disappeared when also the second cysteine was eliminated (in PdeCC75A/ASS), i.e. these bands correspond to a DSB-linked homodimer of PdeCC75A or PdeCASS, respectively. That no such homodimer is observed with PdeCwt also indicates that the formation of the intramolecular DSB is favoured (most likely kinetically) over the formation of the intermolecular DSB required to generate this dimer (or any mixed disulfide with other proteins).
Referee #3:
Herbst et al. present interesting set of observations suggesting involvement of the periplasmic CSS motif (protein domain) in regulating E. coli c-di-GMP
Physiological assays suggest that the proteolytically processed (truncated) form of PdeC has higher PDE activity than the full-length form. However, this argument is not supported by protein quantification that needs to show that the full-length and truncated forms are present in the same concentrations in cells. What would make the authors' argument even more convincing is their comparing PDE activities of the full-length and truncated proteins in vitro.
A: We do not intend to claim that the proteolytically processed form of PdeC has higher activity than the non-DSB form of full size PdeC. That the TM2+EAL construct shows higher activity in vivo than PdeCASS is indeed most likely due to the higher expression of the former (a simple consequence of generating TM2+EAL as well as EAL alone, since these constructs needed new Shine-Dalgarno/start codon configurations and we also paid attention to generate stable constructs according to the N-end rule). The point we actually want to make is that PdeC activity depends on the redox state of its CSS domain. Besides providing genetic evidence, we now also show this with the purified protein reconstituted in nanodiscs (new Fig. 6 ).
A: We now also show similar effects of DTT and knockout mutations in dsbA/degP/degQ for single copy, i.e. chromosomally encoded PdeC (as well as for chromosomally encoded PdeB; see new Fig. 5 ). In addition we show that pdeC deletion as well as deletion of all five genes encoding CSS domain PDEs affect matrix production and architecture specifically in deeper layers in mature macrocolony biofilms (new Fig. 7 ; see also comments to both other Reviewers above)
(ii) Since reducing conditions are presented as the signal to activate PdeC, tests of the pdeC mutant need to be run in the presence and absence of reducing agents.
A: Physiological activity in wildtype compared to pdeC mutant strains requires growth of macrocolonies which takes time (at least 3d; usually we let them grow for 5 d to reach the fully developed morphology). We have grown macrocolonies on agar plates also containing DTT, but DTT is too unstable under these aerobic growth conditions and did not make a difference. However, we also tested the reducing agent N-acetyl-cysteine (NAC; this is actually given to cystic fibrosis patients to apparently reduce biofilm formation of pathogens colonizing the CF lung). NAC seems more stable and we observed effects with macrocolonies grown at 37oC, where biofilm formation is reduced (no more wrinkles are formed since matrix production is lower than at 28oC, but the residual matrix still stains with Congo red): in the presence of NAC, the wildtype strain AR3110 (as well as the strain that chromosomally expresses the highly active/nonredoxregulated PdeCASS variant) shows clearly less CR staining than the strains that lack PdeC or all five CSS domain PDEs indicating that NAC activates PdeCwt.
A: As discussed now on p. 18, we don´t think that this is not a contradiction but may reflect an interesting physiological relationship. c-di-GMP levels are generally 'negotiated' by both DGCs and PDEs being present at certain levels at the same time. Thus, the equally membrane-associated YfiN (now DgcN) may actually be the antagonistic DGC partner for PdeC (or CSS domain PDEs in general). In addition, the control of expression of DgcN is different from CSS domain PDEs: YfiN/DgcN is under σ70 control, i.e. it is present in rapidly growing as well as in stationary phase cells, whereas 4/5 CSS domain PDEs (all except PdeN) are under σS control, i.e. accumulate in stationary phase cells (see Sarenko et al, 2017) . As a result, a dominance of DgcN (over CSS domain PDEs) in growing cells could be a means to allow these cells to generate a biofilm matrix (in particular cellulose) when exposed to reducing stresswhile in stationary phase cells exposed to reducing stress, YfiN/DgcN activity would be neutralized by CSS domain PDEs, with matrix production taking place anyway and being dependent on the σS/CsgD/DgcC pathway (with DgcC activating cellulose synthesis specifically). This is consistent with the study by Hufnagel et al. (2014) which showed that matrix synthesis when driven by YfiN/DgcN is CsgD-independent. In any case, we´ll study this interesting functions of YfiN/DgcN and its antagonistic relationship to CSS domain PDEs further, but this is beyond the scope of the present study.
Furthermore, we have also tested dosC (dgcO) and dosP (pdeO) mutants for any alterations in the extracellular matrix in vertical cryosections of macrocolony biofilms. Unlike for the mutants with alterations in CSS domain PDEs, we did not observe any differences in matrix production and architecture, which indicates that this antagonistic oxygen-regulated DGC/PDE pair does not play a role in matrix formation in this type of biofilm. This suggests that DosC/DosP are either not expressed (although we expect them to be expressed, since they are induced in stationary phase in a strictly σSdependent manner; Sommerfeldt et al, 2009 & Sarenko et al. 2017 or that they may actually control some other c-di-GMP-regulated function (probably in conjunction with the degradosome to which they localize according to Tuckerman et al, 2011). A: We did not mean to say that this toxicity of TM2+EAL overexpression from both vectors is something 'specific' -it may be unspecific in the sense that too much of TM2+EAL (which also has a highly efficient translational start region; see comment above) in the membrane is just harmful for the cell. However, while the standard protocol for this 2H system involves induction of hybrid proteins with IPTG, we now also tried without IPTG addition and it worked just fine at basal expression levels -which also indicates that these interactions are quite specific -and nothing was toxic anymore. Thus, Figs. 4C and D were replaced by new interaction panels obtained without IPTG induction.
The last point of concern is
2nd Editorial Decision 9 January 2018
Thank you for submitting a revised version of your manuscript. The manuscript has now been seen by all original referees, who find that their main concerns have been addressed. There remain only a few minor editorial issues that have to be dealt with before formal acceptance of the manuscript.
For animal studies, include a statement about randomization even if no randomization was used.
4.a. Were any steps taken to minimize the effects of subjective bias during group allocation or/and when assessing results (e.g. blinding of the investigator)? If yes please describe. Any descriptions too long for the figure legend should be included in the methods section and/or with the source data.
Data
the data were obtained and processed according to the field's best practice and are presented to reflect the results of the experiments in an accurate and unbiased manner. figure panels include only data points, measurements or observations that can be compared to each other in a scientifically meaningful way. graphs include clearly labeled error bars for independent experiments and sample sizes. Unless justified, error bars should not be shown for technical replicates. if n< 5, the individual data points from each experiment should be plotted and any statistical test employed should be justified a description of the sample collection allowing the reader to understand whether the samples represent technical or biological replicates (including how many animals, litters, cultures, etc.).
a specification of the experimental system investigated (eg cell line, species name).
NA NA the exact sample size (n) for each experimental group/condition, given as a number, not a range;
Each figure caption should contain the following information, for each panel where they are relevant:
Captions
The data shown in figures should satisfy the following conditions:
Source Data should be included to report the data underlying graphs. Please follow the guidelines set out in the author ship guidelines on Data Presentation.
an explicit mention of the biological and chemical entity(ies) that are altered/varied/perturbed in a controlled manner.
Please fill out these boxes ê (Do not worry if you cannot see all your text once you press return)
In the pink boxes below, please ensure that the answers to the following questions are reported in the manuscript itself. Every question should be answered. If the question is not relevant to your research, please write NA (non applicable). We encourage you to include a specific subsection in the methods section for statistics, reagents, animal models and human subjects.
YOU MUST COMPLETE ALL CELLS WITH A PINK BACKGROUND ê
As good practice for the type of experiments performed and hroughout the study, all experiments were done in three complete biological replicates, except for the in--situ analysis of bacterial biofilms (Fig. 7) , which was done in two complete biological replicates because this type of experiment requires a lot of time and effort. See also Statistics statement in the M&M section.
